ImmunoPrecise Antibodies ... (IPA)
NASDAQ: IPA
· Real-Time Price · USD
3.13
0.50 (19.01%)
At close: Aug 22, 2025, 1:45 PM
ImmunoPrecise Antibodies Income Statement
Financials in CAD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Aug 9, 2023 | Apr 30, 2023 | Jan 31, 2023 | Dec 13, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | 24.52M | 24M | 24.07M | 24.09M | 24.52M | 23.68M | 22.63M | 21.66M | 20.66M | 20.28M | 19.93M | 19.46M | 19.36M | 19M | 18.7M | 18.73M | 17.91M | 17.18M | 16.7M | 15.11M |
Cost of Revenue | 10.97M | 11.8M | 11.97M | 12.48M | 12.46M | 11.39M | 10.58M | 9.79M | 9.1M | 8.74M | 8.77M | 8.51M | 8.38M | 8.56M | 7.28M | 7.1M | 6.37M | 6.48M | 7.33M | 6.04M |
Gross Profit | 13.55M | 12.2M | 12.1M | 11.62M | 12.05M | 12.29M | 12.05M | 11.88M | 11.56M | 11.54M | 11.16M | 10.96M | 10.98M | 10.44M | 11.42M | 11.63M | 11.54M | 10.71M | 9.37M | 9.07M |
Operating Income | -12.2M | -14.26M | -14.3M | -13.79M | -12.33M | -12.43M | -13.61M | -18.17M | -24.81M | -25.35M | -25.1M | -22.9M | -16.47M | -14.78M | -11.47M | -7.46M | -4.13M | -3M | -2.24M | -2.57M |
Interest Income | n/a | n/a | 3K | 13K | 21K | 218K | 254K | 280K | 272K | 184K | 305K | 275K | 279K | 170K | 22K | 531.66K | 527.66K | 745.2K | 733.2K | 259.83K |
Pretax Income | -34.27M | -51.19M | -30.11M | -29.64M | -28.7M | -15.78M | -16.91M | -21.8M | -27.75M | -26.23M | -25.25M | -22.59M | -15.85M | -15.49M | -13.08M | -8.67M | -6M | -3.47M | -2.75M | -3.65M |
Net Income | -30.23M | -46.12M | -27.28M | -27.13M | -26.55M | -13.63M | -15.65M | -20.59M | -26.56M | -26.07M | -25.2M | -22.86M | -16.71M | -17.1M | -14.57M | -10.02M | -7.34M | -3.25M | -2.58M | -3.48M |
Selling & General & Admin | 18.8M | 19.09M | 19.01M | 18.73M | 19.13M | 21.7M | 21.82M | 22.24M | 22.45M | 20.69M | 19.91M | 18.98M | 17.77M | 16.46M | 16.17M | 15.37M | 13.34M | 11.64M | 8.82M | 8.08M |
Research & Development | 4.94M | 4.78M | 4.72M | 4.61M | 3.91M | 3.9M | 4.47M | 8.43M | 13.67M | 14.08M | 14.58M | 12.62M | 7.55M | 6.84M | 4.78M | 2.78M | 1.97M | 1.14M | 1.19M | 588.25K |
Other Expenses | 1.77M | 2.35M | 2.43M | -272K | -3.93M | -9.36M | -13.62M | -18.38M | -24.14M | -18.68M | -18.94M | -16.25M | -9.93M | -10.52M | -7.02M | -4M | -1.26M | -2.03M | -617K | 1.32M |
Operating Expenses | 25.89M | 26.6M | 26.55M | 23.24M | 18.91M | 15.63M | 12.05M | 11.88M | 11.56M | 11.54M | 11.16M | 10.96M | 10.98M | 10.44M | 11.42M | 11.63M | 11.54M | 10.71M | 9.37M | 10.06M |
Interest Expense | 294K | 649K | 482K | 367K | 370K | 42K | 37K | 32K | 32K | 101K | 122K | 142K | 240K | 321.88K | 469.95K | 695.05K | 832.05K | 841.51K | 921.95K | 1M |
Selling & Marketing Expenses | 4.3M | 4.17M | 3.51M | 3.2M | 3.54M | 3.57M | 3.75M | 3.65M | 3.61M | 2.83M | 2.22M | 1.98M | 1.12M | 1.15M | 1.14M | 820.69K | 691K | 656.27K | 488.48K | 293.83K |
Cost & Expenses | 36.86M | 38.4M | 38.52M | 38.03M | 33.69M | 35.38M | 34.54M | 38.13M | 46.09M | 42.49M | 42.39M | 39.24M | 32.87M | 31.96M | 28.82M | 25.32M | 21.9M | 20.28M | 19.04M | 17.78M |
Income Tax Expense | -4.04M | -5.07M | -2.58M | -2.25M | -1.89M | -1.88M | -1.26M | -1.2M | -1.19M | -150K | -46K | 270K | 861K | 1.61M | 1.49M | 1.35M | 1.35M | -214.53K | -165.11K | -160.77K |
Shares Outstanding (Basic) | n/a | 32.85M | 28.13M | 27.13M | 26.95M | 25.8M | 25.05M | 24.74M | 25.03M | 24.95M | 24.87M | 24.74M | 20.76M | 19.43M | 19.34M | 19.22M | 16.87M | 16.9M | 15.65M | 14.48M |
Shares Outstanding (Diluted) | n/a | 32.85M | 28.13M | 27.13M | 26.95M | 25.8M | 25.05M | 24.74M | 25.03M | 24.95M | 24.87M | 24.74M | 20.76M | 19.43M | 19.34M | 19.22M | 16.9M | 16.9M | 15.65M | 14.48M |
EPS (Basic) | -0.9 | -1.57 | -1.01 | -1.02 | -1.01 | -0.54 | -0.63 | -0.83 | -1.07 | -1.09 | -1.1 | -1.06 | -0.85 | -0.93 | -0.81 | -0.58 | -0.44 | -0.21 | -0.18 | -0.25 |
EPS (Diluted) | -0.9 | -1.57 | -1.01 | -1.02 | -1.01 | -0.54 | -0.63 | -0.83 | -1.07 | -1.09 | -1.1 | -1.06 | -0.85 | -0.93 | -0.81 | -0.58 | -0.44 | -0.21 | -0.18 | -0.25 |
EBITDA | -28.86M | -30.14M | -9.32M | -9.23M | -8.13M | -9.74M | -10.49M | -15.06M | -21.02M | -20.26M | -20.01M | -17.86M | -11.61M | -11.44M | -8.89M | -4.22M | -1.45M | 1.63M | 2.13M | 1.09M |
EBIT | -33.98M | -50.89M | -29.98M | -29.63M | -28.62M | -15.67M | -16.82M | -21.71M | -27.72M | -26.12M | -25.13M | -22.45M | -15.61M | -15.17M | -12.61M | -7.97M | -5.16M | -2.63M | -1.83M | -2.64M |
Depreciation & Amortization | 5.11M | 5.78M | 5.69M | 5.64M | 5.74M | 6.14M | 6.52M | 6.63M | 6.68M | 5.63M | 4.89M | 4.36M | 3.77M | 3.73M | 3.72M | 3.76M | 3.71M | 4.26M | 3.93M | 3.62M |